Literature DB >> 28159829

IgA Nephropathy.

Jennifer C Rodrigues1, Mark Haas2, Heather N Reich3,4.   

Abstract

IgA nephropathy (IgAN) is a leading cause of CKD and renal failure. Recent international collaborative efforts have led to important discoveries that have improved our understanding of some of the key steps involved in the immunopathogenesis of IgAN. Furthermore, establishment of multicenter networks has contributed to rigorous design and execution of clinical trials that have provided important insights regarding immunotherapy in IgAN. In this article, we review emerging developments in clinical and translational IgAN research and describe how these novel findings will influence future strategies to improve the outcome of patients with IgAN.
Copyright © 2017 by the American Society of Nephrology.

Entities:  

Keywords:  IGA; IgA nephropathy; chronic; corticosteroids; crescents; glomerulonephritis; humans; immunosuppression; immunotherapy; kidney; pathology; renal insufficiency; review; translational medical research

Mesh：

Substances：

Year:  2017        PMID： 28159829      PMCID： PMC5383386          DOI： 10.2215/CJN.07420716

Source DB:  PubMed          Journal:  Clin J Am Soc Nephrol        ISSN： 1555-9041            Impact factor:   8.237


  70 in total

1.  Overweight/obesity revisited as a predictive risk factor in primary IgA nephropathy.

Authors:  Francois Berthoux; Christophe Mariat; Nicolas Maillard
Journal:  Nephrol Dial Transplant       Date:  2013-09-11       Impact factor: 5.992

2.  Aberrant IgA1 glycosylation is inherited in familial and sporadic IgA nephropathy.

Authors:  Ali G Gharavi; Zina Moldoveanu; Robert J Wyatt; Catherine V Barker; Susan Y Woodford; Richard P Lifton; Jiri Mestecky; Jan Novak; Bruce A Julian
Journal:  J Am Soc Nephrol       Date:  2008-02-13       Impact factor: 10.121

3.  The MEST score provides earlier risk prediction in lgA nephropathy.

Authors:  Sean J Barbour; Gabriela Espino-Hernandez; Heather N Reich; Rosanna Coppo; Ian S D Roberts; John Feehally; Andrew M Herzenberg; Daniel C Cattran
Journal:  Kidney Int       Date:  2016-01       Impact factor: 10.612

4.  Somatic Mutations Modulate Autoantibodies against Galactose-Deficient IgA1 in IgA Nephropathy.

Authors:  Zhi Qiang Huang; Milan Raska; Tyler J Stewart; Colin Reily; R Glenn King; David K Crossman; Michael R Crowley; Audra Hargett; Zhixin Zhang; Hitoshi Suzuki; Stacy Hall; Robert J Wyatt; Bruce A Julian; Matthew B Renfrow; Ali G Gharavi; Jan Novak
Journal:  J Am Soc Nephrol       Date:  2016-03-10       Impact factor: 10.121

5.  Randomized controlled trial of mycophenolate mofetil in children, adolescents, and adults with IgA nephropathy.

Authors:  Ronald J Hogg; R Curtis Bay; J Charles Jennette; Richard Sibley; Sumit Kumar; Fernando C Fervenza; Gerald Appel; Daniel Cattran; Danny Fischer; R Morrison Hurley; Jorge Cerda; Brad Carter; Beverly Jung; German Hernandez; Debbie Gipson; Robert J Wyatt
Journal:  Am J Kidney Dis       Date:  2015-07-21       Impact factor: 8.860

Review 6.  Risk stratification of patients with IgA nephropathy.

Authors:  Sean J Barbour; Heather N Reich
Journal:  Am J Kidney Dis       Date:  2012-04-11       Impact factor: 8.860

7.  IgA nephropathy with minimal change disease.

Authors:  Leal C Herlitz; Andrew S Bomback; Michael B Stokes; Jai Radhakrishnan; Vivette D D'Agati; Glen S Markowitz
Journal:  Clin J Am Soc Nephrol       Date:  2014-04-10       Impact factor: 8.237

Review 8.  Mycophenolate mofetil treatment for IgA nephropathy: a meta-analysis.

Authors:  Gaosi Xu; Weiping Tu; Dongfeng Jiang; Chengyun Xu
Journal:  Am J Nephrol       Date:  2008-10-31       Impact factor: 3.754

Review 9.  New developments in the genetics, pathogenesis, and therapy of IgA nephropathy.

Authors:  Riccardo Magistroni; Vivette D D'Agati; Gerald B Appel; Krzysztof Kiryluk
Journal:  Kidney Int       Date:  2015-09-16       Impact factor: 10.612

Review 10.  The Origin and Activities of IgA1-Containing Immune Complexes in IgA Nephropathy.

Authors:  Barbora Knoppova; Colin Reily; Nicolas Maillard; Dana V Rizk; Zina Moldoveanu; Jiri Mestecky; Milan Raska; Matthew B Renfrow; Bruce A Julian; Jan Novak
Journal:  Front Immunol       Date:  2016-04-12       Impact factor: 7.561
View more
  115 in total

Review 1.  IgA nephropathy: clearance kinetics of IgA-containing immune complexes.

Authors:  Ann Chen; Sung-Sen Yang; Tsai-Jung Lin; Shuk-Man Ka
Journal:  Semin Immunopathol       Date:  2018-09-14       Impact factor: 9.623

2.  Case of summer-type hypersensitivity pneumonitis complicated with IgA nephropathy.

Authors:  Tomoki Maetani; Hiroshi Shima; Yusuke Shiraishi; Satoshi Marumo
Journal:  BMJ Case Rep       Date:  2019-06-18

3.  Mortality Risk in IgA Nephropathy.

Authors:  Richard J Glassock
Journal:  J Am Soc Nephrol       Date:  2019-04-10       Impact factor: 10.121

4.  Genome-Wide Meta-Analysis Identifies Three Novel Susceptibility Loci and Reveals Ethnic Heterogeneity of Genetic Susceptibility for IgA Nephropathy.

Authors:  Ming Li; Ling Wang; Dian-Chun Shi; Jia-Nee Foo; Zhong Zhong; Chiea-Chuen Khor; Chiara Lanzani; Lorena Citterio; Erika Salvi; Pei-Ran Yin; Jin-Xin Bei; Li Wang; Yun-Hua Liao; Jian Chen; Qin-Kai Chen; Gang Xu; Geng-Ru Jiang; Jian-Xin Wan; Meng-Hua Chen; Nan Chen; Hong Zhang; Yi-Xin Zeng; Zhi-Hong Liu; Jian-Jun Liu; Xue-Qing Yu
Journal:  J Am Soc Nephrol       Date:  2020-09-10       Impact factor: 10.121

5.  Impact of body mass index on primary immunoglobulin A nephropathy prognosis: a systematic review and meta-analysis.

Authors:  Qin Wang; Jian-Jiang Zhang; Wen-Jie Dou; Hui-Qin Zeng; Pei-Pei Shi; Jing Wu
Journal:  Int Urol Nephrol       Date:  2021-08-12       Impact factor: 2.370

Review 6.  Dominant C3 glomerulopathy: new roles for an old actor in renal pathology.

Authors:  Nicola Pirozzi; Antonella Stoppacciaro; Paolo Menè
Journal:  J Nephrol       Date:  2017-11-18       Impact factor: 3.902

7.  External Validation of the International IgA Nephropathy Prediction Tool.

Authors:  Junjun Zhang; Bo Huang; Zhangsuo Liu; Xutong Wang; Minhua Xie; Ruxue Guo; Yongli Wang; Dan Yu; Panfei Wang; Yuze Zhu; Jingjing Ren
Journal:  Clin J Am Soc Nephrol       Date:  2020-07-02       Impact factor: 8.237

8.  A man with immunoglobulin A nephropathy complicated by infection-related glomerulonephritis with glomerular depositions of nephritis-associated plasmin receptor.

Authors:  Ayano Onishi; Aya Mizumoto; Kensuke Mitsumoto; Rinko Katsunuma; Takafumi Shingu; Takashi Oda; Takashi Uzu
Journal:  CEN Case Rep       Date:  2021-03-23

Review 9.  The Use of Genomics to Drive Kidney Disease Drug Discovery and Development.

Authors:  Dermot F Reilly; Matthew D Breyer
Journal:  Clin J Am Soc Nephrol       Date:  2020-03-19       Impact factor: 8.237

10.  Urinary exosomal circular RNAs of sex chromosome origin are associated with gender-related risk differences of clinicopathological features in patients with IgA nephropathy.

Authors:  Rumei Luan; Geng Tian; Hong Zhang; Xiaolei Shi; Jicui Li; Rui Zhang; Xuehong Lu
Journal:  J Nephrol       Date:  2021-07-22       Impact factor: 3.902
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.